MLA Shares Public Health Preparedness Insight at Industry Conferences

Other Upcoming Conferences Biogenerics 2007 May 22 - 24, 2007 London, UK Further details about this event can be accessed at http://www.visiongain conferences.com/conference Info.aspx?confID=1077 Federal CBRN Detection R&D Opportunities May 30 - June 1, 2007 Washington, DC Further details about this conference can be accessed at www.infocastinc.com/ biochem07.html. Biodefense Vaccines and Therapeutics June 4-6, 2007 Washington, DC Further information about this event can be accessed at www.infocastinc.com/ biovac07.html.

McKenna Long & Aldridge LLP Shares Public Health Preparedness Insight at Industry Conferences

Representatives from McKenna Long & Aldridge's Public Health Preparedness practice will be attending and speaking at a variety of upcoming conferences. If you are attending any of these events, please contact us so we can arrange a time to connect.

Frank Rapoport:
frapoport@mckennalong.com, 610.517.3405

John Clerici:
jclerici@mckennalong.com, 703.795.4247

Jennifer Hannesschlager:
jhannesschlager@mckennalong.com, 574.210.7468

BIO International Convention
Boston, MA
May 6-9, 2007

Bugs to Drugs: The Next Generation of Antiviral Therapeutics
May 7, 2007
2:00 - 3:30 p.m.
Room Number: 205 A
Dr. Jennifer Hannesschlager, senior science advisor with the Public Health Preparedness team, will discuss the next generation of antiviral therapeutics, innovative technologies these firms are using and challenges they face in developing drugs to combat a growing repertoire of multi-drug-resistant viruses.

Public-Private Partnerships: Driving Product Development in global Vaccines and Biodefense
May 9, 2007
11:00 a.m. - 12:30 p.m.
Room Number 258 C
Frank Rapoport, co-chair of the Public Health Preparedness practice, will lead a panel discussion on public-private partnerships in the United States and their effectiveness in driving product development in Global vaccines and biodefense.

For more information about the BIO International Convention including agendas and registration, please access http://www.bio2007.org/.

Phacilitate Vaccine Forum Munich
Munich, Germany
May 30, 2007- June 1, 2007  

New Strategies for Securing US and EU funds
May 30, 2007
1:00 p.m.
John Clerici will lead a lunch discussion focusing on new strategies for securing US and EU funds for advanced development of antivirals, vaccines for influenza and countermeasures against bioterror pathogens.

National Pandemic Influenza Preparations On A Global Scale: Exploring Market Evolution In Each Case From Public Sector and Industry Perspectives
May 30, 2007
2:30 p.m.
Frank Rapoport, will join biodefense and pharma international leaders from the public and private sectors in this panel discussion.

Please access http://www.phacilitate.co.uk/pages/spring_vaccine/register.html for further information.

About Us
McKenna Long & Aldridge LLP is a international law firm of more than 400 lawyers and public policy advisors. The firm provides business solutions in the areas of corporate law, government contracts, intellectual property and technology, complex litigation, public policy and regulatory affairs, international law, real estate, environmental, energy and finance.

Subscription Info
If you would like others to receive future mailings of the Global Public Health Preparedness Report please email their contact information to us at information@mckennalong.com

If you would like to be removed from the Global Public Health Preparedness Report mailing list, please email information@mckennalong.com.

*This Global Public Health Preparedness Report is for informational purposes only and does not constitute specific legal advice or opinions. Such advice and opinions are provided by the firm only upon engagement with respect to specific factual situations. This message is intended as a transactional message for clients of the Firm. If you are not a client of the Firm, you have received it for informational purposes only and should not consider it an advertisement or solicitation.

This communication may be considered advertising under certain rules regulating the legal profession.